31/03/23 Aesther Healthcare Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
15/02/23 Ocean Biomedical, Aesther Healthcare Acquisition Complete Merger MT
14/02/23 Aesther Healthcare Acquisition Corp.(NasdaqGM:AEHA) dropped from NASDAQ Composite Index CI
14/02/23 Ocean Biomedical, Inc. completed the acquisition of Aesther Healthcare Acquisition Corp. (NasdaqGM : AEHA) from a group of shareholders in a reverse merger transaction. CI
07/02/23 Aesther Healthcare Acquisition, Ocean Biomedical Secure Shareholders Approval for Planned Merger MT
13/12/22 Aesther Healthcare Acquisition Announces Three-Month Extension to Complete Ocean Biomedical Deal MT
18/10/22 Aesther Healthcare Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
20/09/22 Aesther Healthcare Acquisition Pays $1.05 Million Fee to Extend Merger Deadline with Ocean Biomedical MT
19/09/22 Aesther Healthcare Acquisition Corp. has Changed its Name to Ocean Biomedical, Inc CI
12/09/22 Aesther Healthcare Acquisition Receives Board Nod to Extend Time Period to Consummate Business Combination MT
06/09/22 Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Discovery of Bispecific Antibodies CI
31/08/22 Aesther Healthcare Acquisition Signs Merger Deal With Ocean Biomedical MT
31/08/22 Ocean Biomedical, Inc. entered into an Agreement and plan of merger to acquire Aesther Healthcare Acquisition Corp. (NasdaqGM : AEHA) from a group of shareholders in a reverse merger transaction for approximately $430 million. CI
Date Insider Type Main position Quantity % Market Cap.
14/02/23
Aesther Healthcare Sponsor LLC
ConversionCompany 2,625,000 100.9615%
03/11/21
Aesther Healthcare Sponsor LLC
OthersCompany 250,000 9.6154%
03/11/21
Aesther Healthcare Sponsor LLC
OthersCompany 250,000 9.6154%
Logo AESR HEAL
Aesther Healthcare Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination. The Company intends to focus on pharmaceutical and medical devices sectors. The Company has not commenced any operations nor generated any revenue.
Employees
9
Sector
-
  1. Stock Market
  2. Stocks
  3. AEHA Stock